Slim Down for Summer with That's Fit

AOL Money & Finance

Analyst upgrades: UBS, AKAM, HANS, ANSS and AZN

Posted Apr 1st 2008 11:16AM by Eric Buscemi
Filed under: Analyst reports, Analyst upgrades and downgrades, Hansen Natural (HANS), Akamai Technologies (AKAM)

MOST NOTEWORTHY: UBS AG, Ansys and AstraZeneca were today's noteworthy upgrades:
  • Deutsche Bank upgraded shares of UBS AG (NYSE: UBS) to Buy from Hold after the company announced further write-downs and plans to boost capital.
  • Jefferies upgraded shares of Ansys (NASDAQ: ANSS) to Buy from Hold as they like the Ansoft (NASDAQ: ANST) acquisition and feel yesterday's sell-off creates an attractive entry point.
  • AstraZeneca (NYSE: AZN) was raised to Neutral from Underweight at JP Morgan following the positive Crestor study results.
OTHER UPGRADES:
  • Piper raised Akamai (NASDAQ: AKAM) to Buy from Neutral.
  • Goldman upgraded Hansen Natural (NASDAQ: HANS) to Buy from Neutral.
  • Vertex Pharma (NASDAQ: VRTX) was raised to Market Perform from Underperform at Wachovia and to Outperform from Neutral at Baird.

Tags: akamai, anss, ansys, astrazeneca, azn, hans, hansen, inthenews, ubs, vertex, vrtx

  • Permalink
  • Email this
  • Comments [0]

Related Posts

Symbol Lookup
IndexesChangePrice
DJIA+73.0311,288.54
NASDAQ-6.082,245.38
S&P 500+1.381,262.90

Last updated: July 05, 2008: 12:10 AM

BloggingStocks Exclusives

Hot Stocks

BloggingStocks Featured Video

TheFlyOnTheWall.com Headlines

WalletPop Headlines

AOL Business News

Latest from BloggingBuyouts

Sponsored Links

Most Commented On (14 days)

My Portfolios

Track your stocks here!

Find out why more people track their portfolios on AOL Money & Finance then anywhere else.

  • My Portfolio
  • Create a New Portfolio

Weblogs, Inc. Network